614 related articles for article (PubMed ID: 20153300)
1. Noradrenergic lesion of the locus coeruleus increases the firing activity of the medial prefrontal cortex pyramidal neurons and the role of alpha2-adrenoceptors in normal and medial forebrain bundle lesioned rats.
Wang Y; Zhang QJ; Liu J; Ali U; Gui ZH; Hui YP; Wang T; Chen L; Li Q
Brain Res; 2010 Apr; 1324():64-74. PubMed ID: 20153300
[TBL] [Abstract][Full Text] [Related]
2. Noradrenergic lesion of the locus coeruleus increases apomorphine-induced circling behavior and the firing activity of substantia nigra pars reticulata neurons in a rat model of Parkinson's disease.
Wang Y; Zhang QJ; Liu J; Ali U; Gui ZH; Hui YP; Chen L; Wu ZH; Li Q
Brain Res; 2010 Jan; 1310():189-99. PubMed ID: 19896932
[TBL] [Abstract][Full Text] [Related]
3. The firing activity of pyramidal neurons in medial prefrontal cortex and their response to 5-hydroxytryptamine-1A receptor stimulation in a rat model of Parkinson's disease.
Wang S; Zhang QJ; Liu J; Wu ZH; Ali U; Wang Y; Chen L; Gui ZH
Neuroscience; 2009 Sep; 162(4):1091-100. PubMed ID: 19410634
[TBL] [Abstract][Full Text] [Related]
4. Changes in firing rate and pattern of GABAergic neurons in subregions of the substantia nigra pars reticulata in rat models of Parkinson's disease.
Wang Y; Zhang QJ; Liu J; Ali U; Gui ZH; Hui YP; Chen L; Wang T
Brain Res; 2010 Apr; 1324():54-63. PubMed ID: 20149784
[TBL] [Abstract][Full Text] [Related]
5. The pyramidal neurons in the medial prefrontal cortex show decreased response to 5-hydroxytryptamine-3 receptor stimulation in a rodent model of Parkinson's disease.
Zhang QJ; Li LB; Niu XL; Liu J; Gui ZH; Feng JJ; Ali U; Hui YP; Wu ZH
Brain Res; 2011 Apr; 1384():69-79. PubMed ID: 21291871
[TBL] [Abstract][Full Text] [Related]
6. α2-Adrenoceptor regulates the spontaneous and the GABA/glutamate modulated firing activity of the rat medial prefrontal cortex pyramidal neurons.
Wang Y; Liu J; Gui ZH; Ali U; Fan LL; Hou C; Wang T; Chen L; Li Q
Neuroscience; 2011 May; 182():193-202. PubMed ID: 21402127
[TBL] [Abstract][Full Text] [Related]
7. In vivo effect of 5-HT₇ receptor agonist on pyramidal neurons in medial frontal cortex of normal and 6-hydroxydopamine-lesioned rats: an electrophysiological study.
Fan LL; Zhang QJ; Liu J; Feng J; Gui ZH; Ali U; Zhang L; Hou C; Wang T; Hui YP; Sun YN; Wu ZH
Neuroscience; 2011 Sep; 190():328-38. PubMed ID: 21684321
[TBL] [Abstract][Full Text] [Related]
8. In vivo effects of activation and blockade of 5-HT(2A/2C) receptors in the firing activity of pyramidal neurons of medial prefrontal cortex in a rodent model of Parkinson's disease.
Wang S; Zhang QJ; Liu J; Ali U; Wu ZH; Chen L; Gui ZH; Wang Y; Hui YP
Exp Neurol; 2009 Sep; 219(1):239-48. PubMed ID: 19500571
[TBL] [Abstract][Full Text] [Related]
9. In vivo modulation of the firing activity of putative slow- and fast-spiking interneurons in the medial prefrontal cortex by 5-HT3 receptors in 6-hydroxydopamine-induced Parkinsonian rats.
Gui ZH; Zhang QJ; Liu J; Ali U; Li LB; Wang Y; Wang T; Chen L; Hou C; Fan LL
Neuroscience; 2010 Sep; 169(3):1315-25. PubMed ID: 20576497
[TBL] [Abstract][Full Text] [Related]
10. Activation of 5-HT₁A receptors in the medial subdivision of the central nucleus of the amygdala produces anxiolytic effects in a rat model of Parkinson's disease.
Sun YN; Wang T; Wang Y; Han LN; Li LB; Zhang YM; Liu J
Neuropharmacology; 2015 Aug; 95():181-91. PubMed ID: 25797491
[TBL] [Abstract][Full Text] [Related]
11. Anxiolytics antagonize yohimbine-induced central noradrenergic activity: a concomitant in vivo voltammetry-electrophysiology model of anxiety.
Crespi F
J Neurosci Methods; 2009 May; 180(1):97-105. PubMed ID: 19427535
[TBL] [Abstract][Full Text] [Related]
12. Neurochemical interaction between dopaminergic and noradrenergic neurons in the medial prefrontal cortex.
Pan WH; Yang SY; Lin SK
Synapse; 2004 Jul; 53(1):44-52. PubMed ID: 15150740
[TBL] [Abstract][Full Text] [Related]
13. Origin of extracellular dopamine from dopamine and noradrenaline neurons in the medial prefrontal and occipital cortex.
Devoto P; Flore G; Longu G; Pira L; Gessa GL
Synapse; 2003 Dec; 50(3):200-5. PubMed ID: 14515337
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the firing activity of noradrenergic neurones in the rat locus coeruleus by the 5-hydroxtryptamine system.
Haddjeri N; de Montigny C; Blier P
Br J Pharmacol; 1997 Mar; 120(5):865-75. PubMed ID: 9138693
[TBL] [Abstract][Full Text] [Related]
15. Effects of long-term desipramine administration on noradrenergic neurotransmission: electrophysiological studies in the rat brain.
Lacroix D; Blier P; Curet O; de Montigny C
J Pharmacol Exp Ther; 1991 Jun; 257(3):1081-90. PubMed ID: 1646320
[TBL] [Abstract][Full Text] [Related]
16. Behavioral differences in a rotenone-induced hemiparkinsonian rat model developed following intranigral or median forebrain bundle infusion.
Sindhu KM; Saravanan KS; Mohanakumar KP
Brain Res; 2005 Jul; 1051(1-2):25-34. PubMed ID: 15992782
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats.
Srinivasan J; Schmidt WJ
Eur J Neurosci; 2003 Jun; 17(12):2586-92. PubMed ID: 12823465
[TBL] [Abstract][Full Text] [Related]
18. Unilateral lesion of the nigrostriatal pathway decreases the response of GABA interneurons in the dorsal raphe nucleus to 5-HT(1A) receptor stimulation in the rat.
Hou C; Xue L; Feng J; Zhang L; Wang Y; Chen L; Wang T; Zhang QJ; Liu J
Neurochem Int; 2012 Dec; 61(8):1344-56. PubMed ID: 23032407
[TBL] [Abstract][Full Text] [Related]
19. Treatment with alpha2-adrenoceptor antagonist, 2-methoxy idazoxan, protects 6-hydroxydopamine-induced Parkinsonian symptoms in rats: neurochemical and behavioral evidence.
Srinivasan J; Schmidt WJ
Behav Brain Res; 2004 Oct; 154(2):353-63. PubMed ID: 15313023
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of locus coeruleus neurons by non-I1/I2-type imidazoline receptors: an in vivo and in vitro electrophysiological study.
Ugedo L; Pineda J; Ruiz-Ortega JA; Martín-Ruiz R
Br J Pharmacol; 1998 Dec; 125(8):1685-94. PubMed ID: 9886760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
